Exact Mass: 422.2278
Exact Mass Matches: 422.2278
Found 500 metabolites which its exact mass value is equals to given mass value 422.2278
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Fludrocortisone acetate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials CONFIDENCE standard compound; INTERNAL_ID 2101 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
1-Octen-3-yl primeveroside
1-Octen-3-yl primeveroside is found in herbs and spices. 1-Octen-3-yl primeveroside is a constituent of spearmint (Mentha spicata var. crispa). Constituent of spearmint (Mentha spicata variety crispa). 1-Octen-3-yl primeveroside is found in herbs and spices.
2,2-Dibutyl-3-(4-methoxyphenyl)-4-methyl-2H-1-benzopyran-7-ol acetate
Fludrocortisone acetate
1H-2-Benzopyran-6-carboxamide, 1-(2-(4-(4-(aminocarbonyl)phenyl)-1-piperazinyl)ethyl)-3,4-dihydro-N-methyl-, (1S)-
1,4,2-Trihydroxy-3,5-dioxo-1,4,4-trimethyl-4-prenyl-2,3,3a,4,7,7a-hexahydrospiro[1H-indene-6(5H),1-cyclopentane]-2-carboxylic acid methyl ester
oct-1-en-3-yl alpha-arabinofuranosyl-(1->6)-beta-glucopyranoside
methyl-4E-9beta-acetoxy-14-O-(2-methylbutyryl)-oxyphylloate|methyl-4E-9beta-acetoxy-14-O-<2-methylbutyryl>-oxyphylloate
6beta,7beta,14beta,18-tetrahydroxy-16beta-acetonylmethyl-7alpha,20-epoxy-ent-kaur-15-one|parvifoline R
16(R)-7alpha,14beta-dihydroxy-17-methoxy-3beta-acetoxy-ent-kaur-12,15-dione|17-methoxydihydropseurata C|pharicunin I
(1R*,3R*,4S*,13R*,14R*,15S*,7E,11E)-13-hydroxy-18-acetoxy-17-methoxy-3,4-epoxycembra-7,11-dien-16,14-olide|durumolide O
7alpha,14beta-dihydroxy-17alpha-methoxymethyl-18beta-acetoxy-ent-kaur-11,15-dione
12alpha-methoxyl-5alpha,7beta-dihydroxy-1alpha-acetoxycass-13(15)-en-16,12-olide|neocaesalpin AB
7alpha,14beta-dihydroxy-17beta-methoxymethyl-3beta-acetoxy-ent-kaur-11,15-dione
(ent-15beta)-Benzoyl-15-Hydroxy-16-kauren-19-oic acid|Benzoyl-15-Hydroxy-16-kauren-19-oic acid
6beta,7beta,11beta,14beta-tetrahydroxy-16beta-acetonylmethyl-7alpha,20-epoxy-ent-kaur-15-one|parvifoline T
methyl 7alpha-acetoxy-1alpha,11alpha,14alpha-trihydroxy-8,15-isopimaradien-18-oate
11-Ac-(3beta,11alpha,12beta,14beta,17alpha)-3,8,11,12,14-Pentahydroxypregn-5-en-20-one
15-malonyloxy-7alpha-hydroxy-ent-clerod-3-en-18,19-olide
fludrocortisone
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials CONFIDENCE standard compound; EAWAG_UCHEM_ID 3240 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(2R,3S,4S,5R,6R)-2-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-6-oct-1-en-3-yloxyoxane-3,4,5-triol
2-oct-1-en-3-yloxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxane-3,4,5-triol
Ala Ala Val Tyr
Ala Ala Tyr Val
Ala Phe Ser Val
Ala Phe Val Ser
Ala Gly Ile Tyr
Ala Gly Leu Tyr
Ala Gly Tyr Ile
Ala Gly Tyr Leu
Ala His Pro Val
Ala His Val Pro
Ala Ile Gly Tyr
Ala Ile Tyr Gly
Ala Leu Gly Tyr
Ala Leu Tyr Gly
Ala Pro His Val
Ala Pro Val His
Ala Ser Phe Val
Ala Ser Val Phe
Ala Val Ala Tyr
Ala Val Phe Ser
Ala Val His Pro
Ala Val Pro His
Ala Val Ser Phe
Ala Val Tyr Ala
Ala Tyr Ala Val
Ala Tyr Gly Ile
Ala Tyr Gly Leu
Ala Tyr Ile Gly
Ala Tyr Leu Gly
Ala Tyr Val Ala
Phe Ala Ser Val
Phe Ala Val Ser
Phe Gly Ile Ser
Phe Gly Leu Ser
Phe Gly Ser Ile
Phe Gly Ser Leu
Phe Gly Thr Val
Phe Gly Val Thr
Phe Ile Gly Ser
Phe Ile Ser Gly
Phe Leu Gly Ser
Phe Leu Ser Gly
Phe Ser Ala Val
Phe Ser Gly Ile
Phe Ser Gly Leu
Phe Ser Ile Gly
Phe Ser Leu Gly
Phe Ser Val Ala
Phe Thr Gly Val
Phe Thr Val Gly
Phe Val Ala Ser
Phe Val Gly Thr
Phe Val Ser Ala
Phe Val Thr Gly
Gly Ala Ile Tyr
Gly Ala Leu Tyr
Gly Ala Tyr Ile
Gly Ala Tyr Leu
Gly Phe Ile Ser
Gly Phe Leu Ser
Gly Phe Ser Ile
Gly Phe Ser Leu
Gly Phe Thr Val
Gly Phe Val Thr
Gly His Ile Pro
Gly His Leu Pro
Gly His Pro Ile
Gly His Pro Leu
Gly Ile Ala Tyr
Gly Ile Phe Ser
Gly Ile His Pro
Gly Ile Pro His
Gly Ile Ser Phe
Gly Ile Tyr Ala
Gly Leu Ala Tyr
Gly Leu Phe Ser
Gly Leu His Pro
Gly Leu Pro His
Gly Leu Ser Phe
Gly Leu Tyr Ala
Gly Pro His Ile
Gly Pro His Leu
Gly Pro Ile His
Gly Pro Leu His
Gly Ser Phe Ile
Gly Ser Phe Leu
Gly Ser Ile Phe
Gly Ser Leu Phe
Gly Thr Phe Val
Gly Thr Val Phe
Gly Val Phe Thr
Gly Val Thr Phe
Gly Tyr Ala Ile
Gly Tyr Ala Leu
Gly Tyr Ile Ala
Gly Tyr Leu Ala
His Ala Pro Val
His Ala Val Pro
His Gly Ile Pro
His Gly Leu Pro
His Gly Pro Ile
His Gly Pro Leu
His Ile Gly Pro
His Ile Pro Gly
His Leu Gly Pro
His Leu Pro Gly
His Pro Ala Val
His Pro Gly Ile
His Pro Gly Leu
His Pro Ile Gly
His Pro Leu Gly
His Pro Val Ala
His Val Ala Pro
His Val Pro Ala
Ile Ala Gly Tyr
Ile Ala Tyr Gly
Ile Phe Gly Ser
Ile Phe Ser Gly
Ile Gly Ala Tyr
Ile Gly Phe Ser
Ile Gly His Pro
Ile Gly Pro His
Ile Gly Ser Phe
Ile Gly Tyr Ala
Ile His Gly Pro
Ile His Pro Gly
Ile Pro Gly His
Ile Pro His Gly
Ile Ser Phe Gly
Ile Ser Gly Phe
Ile Tyr Ala Gly
Ile Tyr Gly Ala
Leu Ala Gly Tyr
Leu Ala Tyr Gly
Leu Phe Gly Ser
Leu Phe Ser Gly
Leu Gly Ala Tyr
Leu Gly Phe Ser
Leu Gly His Pro
Leu Gly Pro His
Leu Gly Ser Phe
Leu Gly Tyr Ala
Leu His Gly Pro
Leu His Pro Gly
Leu Pro Gly His
Leu Pro His Gly
Leu Ser Phe Gly
Leu Ser Gly Phe
Leu Tyr Ala Gly
Leu Tyr Gly Ala
Pro Ala His Val
Pro Ala Val His
Pro Gly His Ile
Pro Gly His Leu
Pro Gly Ile His
Pro Gly Leu His
Pro His Ala Val
Pro His Gly Ile
Pro His Gly Leu
Pro His Ile Gly
Pro His Leu Gly
Pro His Val Ala
Pro Ile Gly His
Pro Ile His Gly
Pro Leu Gly His
Pro Leu His Gly
Pro Val Ala His
Pro Val His Ala
Ser Ala Phe Val
Ser Ala Val Phe
Ser Phe Ala Val
Ser Phe Gly Ile
Ser Phe Gly Leu
Ser Phe Ile Gly
Ser Phe Leu Gly
Ser Phe Val Ala
Ser Gly Phe Ile
Ser Gly Phe Leu
Ser Gly Ile Phe
Ser Gly Leu Phe
Ser Ile Phe Gly
Ser Ile Gly Phe
Ser Leu Phe Gly
Ser Leu Gly Phe
Ser Val Ala Phe
Ser Val Phe Ala
Thr Phe Gly Val
Thr Phe Val Gly
Thr Gly Phe Val
Thr Gly Val Phe
Thr Val Phe Gly
Thr Val Gly Phe
Val Ala Ala Tyr
Val Ala Phe Ser
Val Ala His Pro
Val Ala Pro His
Val Ala Ser Phe
Val Ala Tyr Ala
Val Phe Ala Ser
Val Phe Gly Thr
Val Phe Ser Ala
Val Phe Thr Gly
Val Gly Phe Thr
Val Gly Thr Phe
Val His Ala Pro
Val His Pro Ala
Val Pro Ala His
Val Pro His Ala
Val Ser Ala Phe
Val Ser Phe Ala
Val Thr Phe Gly
Val Thr Gly Phe
Val Tyr Ala Ala
Tyr Ala Ala Val
Tyr Ala Gly Ile
Tyr Ala Gly Leu
Tyr Ala Ile Gly
Tyr Ala Leu Gly
Tyr Ala Val Ala
Tyr Gly Ala Ile
Tyr Gly Ala Leu
Tyr Gly Ile Ala
Tyr Gly Leu Ala
Tyr Ile Ala Gly
Tyr Ile Gly Ala
Tyr Leu Ala Gly
Tyr Leu Gly Ala
Tyr Val Ala Ala
1-Octen-3-yl primeveroside
1,4-bis[(2-ethylhexyl)oxy]-1,4-dioxobutane-2-sulfonic acid
(-)-Sparteine sulfate pentahydrate
C15H26N2. H2SO4.5H2O (422.2298)
Benzyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate
ETHYL 2-(4-(4-(4-AMINO-7,7-DIMETHYL-7H-PYRIMIDO[4,5-B][1,4]OXAZIN-6-YL)PHENYL)CYCLOHEXYL)ACETATE
2-benzofuran-1,3-dione,2,2-bis(hydroxymethyl)butyl 7-methyloctanoate
(2S,3S,4S)-4-amino-2,3-dihydroxy-N-{(1S)-1-[(3S)-8-hydroxy-1-oxo-3,4-dihydro-1H-isochromen-3-yl]-3-methylbutyl}-6-methylheptanamide
N-[4-[5-[[1-[(3-fluoro-2-methylphenyl)methyl]piperidin-3-yl]methyl]-1,2,4-oxadiazol-3-yl]phenyl]acetamide
1H-2-Benzopyran-6-carboxamide, 1-(2-(4-(4-(aminocarbonyl)phenyl)-1-piperazinyl)ethyl)-3,4-dihydro-N-methyl-, (1S)-
[(1E,3S,4R,10R,11S)-3,9,14-trihydroxy-14-(methoxymethyl)-4,10-dimethyl-5-oxo-6-propan-2-yl-4-tricyclo[9.3.0.03,7]tetradeca-1,6-dienyl] acetate
(-)-(5E,12E,2S,3S,4S,9S,11S,15R)-15-benzoyloxylathyra-5,12-dien-3-ol-14-one
A lathyrane diterpenoid isolated from the roots of Euphorbia micractina.
Sarmentologenin
A steroid lactone that is card-20(22)-enolide substituted by hydroxy groups at positions 3, 5, 11, 14 and 19.
(2R*,3R*)-3-{[(2S)-1-({4-[(3-aminopropyl)amino]butyl}amino)-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]carbamoyl}oxirane-2-carboxylic acid
(2R*,3R*)-3-{[(2S)-1-({3-[(4-aminobutyl)amino]propyl}amino)-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]carbamoyl}oxirane-2-carboxylic acid
4-[[anilino-(4-methylphenyl)methyl]-propoxyphosphoryl]-N,N-dimethylaniline
N-[4-[4-[[1-oxo-2-(1-pyrrolidinyl)ethyl]amino]phenoxy]phenyl]-2-(1-pyrrolidinyl)acetamide
3-[3,5-dimethyl-1-[6-(1-piperidinyl)-3-pyridazinyl]-4-pyrazolyl]-N-(3-fluorophenyl)propanamide
N-[1-(phenylmethyl)-4-piperidinyl]-2-(2-pyridinyl)-4-quinolinecarboxamide
(2R,3S,4S,5R,6R)-2-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-6-oct-1-en-3-yloxyoxane-3,4,5-triol
2-[(1S,3S,4aS,9aR)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone
2-[(1S,3R,4aS,9aR)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone
2-[(1S,3R,4aR,9aS)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone
2-[(1S,3S,4aR,9aS)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone
(2R)-2-[(4R,5R)-8-(1-cyclohexenyl)-5-[(dimethylamino)methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
2-[(1R,3R,4aS,9aR)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone
(2R)-2-[(4S,5S)-8-(1-cyclohexenyl)-5-[(dimethylamino)methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4R,5R)-8-(1-cyclohexenyl)-5-[(dimethylamino)methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
2-[(1R,3S,4aS,9aR)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone
[(1R,2aS,8bS)-1-(hydroxymethyl)-2-(4-oxanylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(2-methoxyphenyl)methanone
[(1S,2aR,8bR)-1-(hydroxymethyl)-2-(4-oxanylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(2-methoxyphenyl)methanone
[(1S,2aS,8bS)-1-(hydroxymethyl)-2-(4-oxanylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(2-methoxyphenyl)methanone
(2R,3R,3aS,9bS)-N-cyclobutyl-3-(hydroxymethyl)-6-oxo-1-propyl-7-(3-pyridinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2S,3S,3aR,9bR)-N-cyclobutyl-3-(hydroxymethyl)-6-oxo-1-propyl-7-(3-pyridinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
N-[4-[5-[[(3R)-1-[(3-fluoro-2-methylphenyl)methyl]piperidin-3-yl]methyl]-1,2,4-oxadiazol-3-yl]phenyl]acetamide
(2-hydroxy-3-phosphonooxypropyl) (Z)-heptadec-9-enoate
[1-Acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] octanoate
[1-Butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] hexanoate
[2-Pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] pentanoate
[1-Propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] heptanoate
2-[(E)-5-Ethoxycarbonyl-4-pentenyl]-4-oxo-7,7-(ethylenedioxy)decahydronaphthalene-1-carboxylic acid ethyl ester
Fludrocortisone acetate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
1-Octen-3-ol-3-o-beta-D-xylopyranosyl(1->6)-beta-D-glucopyranoside
PM-94128
A a monocarboxylic acid amide obtained by the formal condensation of the amino group of 3-[(1S)-1-amino-3-methylbutyl]-8-hydroxy-3,4-dihydro-1H-isochromen-1-one with the carboxy group of 4-amino-2,3-dihydroxy-6-methylheptanoic acid (the 2S,3S,4S stereoisomer). It is isolated from the culture broth of Bacillus sp.PhM-PHD-090 and exhibits potent antitumour activity.
6alpha-Fluoro-17-hydroxycorticosterone 21-acetate
TMC-52A
An epoxide which is a carboxamide obtained by the formal condensation of one of the carboxy groups of oxirane-2,3-dicarboxylic acid with N-{3-[(4-aminobutyl)amino]propyl}-L-tyrosinamide. It is a natural product, isolated from Gliocladium sp. F-2665. TMC-52A acts as an inhibitor of cysteine proteinases, particularly cathepsin B (EC 3.4.22.1), cathepsin L (EC 3.4.22.15), and papain (EC 3.4.22.2); IC50 values are 320 nM, 13 nM, and 44 nM, respectively. The epoxide group has trans configuration but its exact stereochemistry is uncertain: it is either (2R,3R) or (2S,3S).
TMC-52B
An epoxide which is a carboxamide obtained by the formal condensation of one of the carboxy groups of oxirane-2,3-dicarboxylic acid with N-{4-[(3-aminopropyl)amino]butyl}-L-tyrosinamide. It is a natural product, isolated from Gliocladium sp. F-2665. TMC-52B acts as an inhibitor of cysteine proteinases, particularly cathepsin B (EC 3.4.22.1), cathepsin L (EC 3.4.22.15), and papain (EC 3.4.22.2); IC50 values are 200 nM, 10 nM, and 7 nM, respectively. The epoxide group has trans configuration but its exact stereochemistry is uncertain: it is either (2R,3R) or (2S,3S).
1-Heptadecanoyl-sn-glycero-3-phosphate(2-)
A 1-acyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-heptadecanoyl-sn-glycero-3-phosphate.
(+)-Sparteine (sulfate pentahydrate)
(+)-sparteine (sulfate pentahydrate) is a ganglionic blocking agent. (+)-Sparteine competitively blocks nicotinic ACh receptor in the neurons[1].
(+)-Sparteine (sulfate pentahydrate)
(+)-sparteine (sulfate pentahydrate) is a ganglionic blocking agent. (+)-Sparteine competitively blocks nicotinic ACh receptor in the neurons[1].
KT109
KT109 is a potent and an isoform-selective inhibitor of?diacylglycerol lipase-β (DAGLβ) with an IC50 of 42 nM. KT109 has ~60-fold selectivity for DAGLβ over DAGLα. KT109 shows inhibitory activity against PLA2G7 (IC50=1 μM). KT109 shows negligible activity against FAAH, MGLL, ABHD11, and cytosolic phospholipase A2 (cPLA2 or PLA2G4A). KT109 perturbs a lipid network involved in macrophage inflammatory responses and lowers 2-arachidonoylglycerol (2-AG), arachidonic acid and eicosanoids in mouse peritoneal macrophages[1].
(1s,2s,3r,5s,6s,8s,9s,10s,11r)-9,10-dihydroxy-6-(methoxymethyl)-12,12-dimethyl-7-oxo-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-3-yl acetate
(2r,3r,4s,5s,6r)-2-[(3r)-oct-1-en-3-yloxy]-6-({[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol
(2e)-n-(2-hydroxy-1-{[(3e,8s,10r)-2,7,10-trihydroxy-5-methyl-1,6-diazacyclododeca-1,3,6-trien-8-yl]-c-hydroxycarbonimidoyl}propyl)penta-2,4-dienimidic acid
3-{[(3s)-5-[(6ar,7r,8s,9r,10as)-9-hydroxy-7,8-dimethyl-3-oxo-1h,5h,6h,6ah,8h,9h,10h-naphtho[4,4a-c]furan-7-yl]-3-methylpentyl]oxy}-3-oxopropanoic acid
(2r,3s,3ar,5r,6s,7as)-5,7a-dimethoxy-3-methyl-3a-(prop-2-en-1-yl)-2-(3,4,5-trimethoxyphenyl)-hexahydro-1-benzofuran-6-ol
6-hydroxy-9-isopropoxy-6,10-dimethyl-3-methylidene-2,7-dioxo-octahydrocyclodeca[b]furan-4-yl 2-methylbut-2-enoate
1,7,11,14-tetrahydroxy-8,15-isopimaradien-18-oic acid; (1α,7α,11α,14α)-form,7-ac,me ester
{"Ingredient_id": "HBIN001966","Ingredient_name": "1,7,11,14-tetrahydroxy-8,15-isopimaradien-18-oic acid; (1\u03b1,7\u03b1,11\u03b1,14\u03b1)-form,7-ac,me ester","Alias": "NA","Ingredient_formula": "C23H34O7","Ingredient_Smile": "NA","Ingredient_weight": "422.51","OB_score": "NA","CAS_id": "263873-68-3","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9481","PubChem_id": "NA","DrugBank_id": "NA"}